.
.
.
.
.
.
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
español
.
follow mailonline
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
.